GMAB
Genmab AS
NASDAQ: GMAB · HEALTHCARE · BIOTECHNOLOGY
$26.11
-2.54% today
Updated 2026-04-29
Market cap
$16.45B
P/E ratio
17.40
P/S ratio
4.42x
EPS (TTM)
$1.54
Dividend yield
—
52W range
$19 – $35
Volume
1.7M
Genmab AS (GMAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-379.62M | $505.90M | $-513.33M | $-570.06M | $268.17M | $-437.23M | $70.92M | $-128.00M | $132.67M | $311.45M | $327.72M | $1.59B | $1.01B | $1.33B | $6.43B | $2.23B | $3.91B | $7.38B | $7.77B | $1.19B |
| Capital expenditures | $1.94M | $12.84M | $53.02M | $16.78M | $10.11M | $7.21M | $9.00M | $10.37M | $75.44M | $135.39M | $33.11M | $88.51M | $477.37M | $111.00M | $307.00M | $252.00M | $317.00M | $376.00M | $187.00M | $37.03M |
| Depreciation | $17.50M | $14.25M | $85.09M | $83.78M | $21.03M | $15.05M | $15.11M | $11.66M | $12.33M | $31.82M | $40.96M | $69.75M | $87.60M | $139.00M | $266.00M | $248.00M | $362.00M | $295.00M | $413.00M | — |
| Stock-based comp | — | — | — | — | — | $20.04M | $12.00M | $11.57M | $27.72M | $36.56M | $53.19M | $75.98M | $90.76M | $147.00M | $200.00M | $310.00M | $439.00M | $586.00M | $721.00M | $128.00M |
| Free cash flow | $-381.56M | $493.06M | $-566.35M | $-586.84M | $258.06M | $-444.43M | $61.92M | $-138.36M | $57.23M | $176.06M | $294.61M | $1.50B | $537.42M | $1.22B | $6.13B | $1.98B | $3.60B | $7.00B | $7.58B | $1.15B |
| Investing cash flow | $-451.37M | $-2.36B | $460.10M | $974.73M | $-738.50M | $514.75M | $-416.34M | $66.95M | $-1.01B | $-480.88M | $-1.01B | $-667.57M | $-1.78B | $-1.98B | $-2.35B | $-961.00M | $-2.76B | $-1.28B | $-9.91B | — |
| Financing cash flow | $879.03M | $1.56B | $25.29M | $-6.64M | $-7.00M | $-6.09M | $357.81M | $151.66M | $1.04B | $643.09M | $91.19M | $214.91M | $-70.90M | $3.66B | $71.00M | $-420.00M | $-789.00M | $-606.00M | $-3.92B | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $9.00M | $115.00M | $135.00M | $280.00M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |